Mypher Pharmaceuticals Llp Profile
Key Indicators
- Obligation of Contribution ₹ 0.10 M
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 9.22 Cr
- Satisfied Charges ₹ 4.99 Cr
About Mypher Pharmaceuticals Llp
Mypher Pharmaceuticals Llp (MPL) is 10 Year, 4 Months old Limited Liability Partnership 10 October 2014. Its registered office is in Vadodara, Gujarat, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2022 (FY 2021-2022). It's Total Obligation of Contribution is Rs 0.10 M as per MCA.
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN/FCRN
AAC-7995
- Incorporation Date
10 Oct 2014
- Date of Accounts and Solvency Statement
31 Mar 2022
- ROC Code
Roc-Ahmedabad
- Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Mypher Pharmaceuticals Llp?
Designated Partners (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nandkishore Maheshwari  | Designated Partner | 10-Oct-2014 | Current |
| Vedant Maheshwari | Designated Partner | 10-Oct-2014 | Current |
Financial Performance of Mypher Pharmaceuticals Llp.
Enhance accessibility to Mypher Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Mypher Pharmaceuticals Llp?
Unlock access to Mypher Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Savorite Pharmaceuticals Private LimitedNandkishore Maheshwari and Vedant Maheshwari are mutual person
Ronald Pharmaceuticals Private LimitedNandkishore Maheshwari and Vedant Maheshwari are mutual person
Avenza Pharmaceuticals Private LimitedVedant Maheshwari is a mutual person
Charges (Loans)
₹92.20 M
₹49.90 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 9.22 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jul 2020 | State Bank Of India | ₹4.61 Cr | Open |
| 07 Dec 2019 | State Bank Of India | ₹4.61 Cr | Open |
| 14 Dec 2015 | Indusind Bank Ltd | ₹2.00 Cr | Satisfied |
| 27 Nov 2015 | Indusind Bank Ltd | ₹2.00 Cr | Satisfied |
| 24 Apr 2015 | Punjab National Bank | ₹9.90 M | Satisfied |
How Many Employees Work at Mypher Pharmaceuticals Llp?
Mypher Pharmaceuticals Llp has a workforce of 183 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mypher Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mypher Pharmaceuticals Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.